Cybersecurity experts are reviewing the resignation of Jen Easterly, Director of the Cybersecurity and Infrastructure Security Agency, and its potential impact on national cybersecurity efforts.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
